Obstetrics & Gynaecology · Cervical Carcinoma (Risk Factors, Staging, Treatment)

Following radical hysterectomy with pelvic lymphadenectomy for Stage IB1 cervical cancer, final histopathology shows a 3.2 cm tumour with deep stromal invasion, lymphovascular space invasion, and one positive right obturator lymph node with negative margins. What is the appropriate adjuvant therapy?

  • A Concurrent weekly cisplatin with pelvic external beam radiotherapy
  • B Vaginal brachytherapy alone
  • C Observation with close surveillance
  • D Six cycles of paclitaxel and carboplatin alone
Correct answer: A. Concurrent weekly cisplatin with pelvic external beam radiotherapy

Explanation

Positive lymph nodes, positive resection margins and microscopic parametrial involvement are high-risk features that mandate adjuvant concurrent chemoradiation, based on evidence that adding cisplatin to pelvic radiotherapy improves survival in this setting. Sedlis criteria apply to intermediate-risk patients with node-negative disease, so observation or brachytherapy alone would undertreat nodal metastasis, and chemotherapy alone is not established as adjuvant therapy.

Reference: Williams Gynecology, 4th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs

See all Cervical Carcinoma (Risk Factors, Staging, Treatment) MCQs →